Zhejiang Ausun Pharmaceutical Co., Ltd. Stock: price and insider trades · China
奥翔药业
Zhejiang Ausun Pharmaceutical Co., Ltd.: what insiders have been doing
Zhejiang Ausun Pharmaceutical Co., Ltd. belongs to the Health Care sector. Filings by its managers are published through SSE / SZSE (CSRC). Nothing new has been filed by managers of Zhejiang Ausun Pharmaceutical Co., Ltd. in twelve months, the latest record being from 21 December 2022.
Since 2022, the database holds no purchases and 9 sales by insiders of the company.
For comparison within the same sector, see the insider buying recorded at Dynavox Group AB and Vetoquinol SA. Every figure here comes from the filings published by SSE / SZSE (CSRC) and describes the past, not future prices; it is not investment advice.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
- 1,312,400 shares100.0% of flowA股XSHGSSE:173000006147357900
- 150,000 shares35.3% of flowA股XSHGSSE:173000006130584130
- 5,000,000 shares99.4% of flowA股XSHGSSE:173000006130584160
- 120,000 shares25.7% of flowA股XSHGSSE:173000006124196670
- 160,000 shares20.5% of flowA股XSHGSSE:173000006118314180
- 20,000 shares0.6% of flowA股XSHGSSE:173000005714677500
- 320,000 shares79.5% of flowA股XSHGSSE:173000005711293540
- 20,100 shares8.6% of flowA股XSHGSSE:173000005700564450
- 70,000 shares30.4% of flowA股XSHGSSE:173000005662403420
9 of 9 declarations
About Zhejiang Ausun Pharmaceutical Co., Ltd.
奥翔药业 is a company in the health and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and commercialization of innovative drugs.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
